Worldwide shipping · 120+ destinationsCOA & GHS SDS with every lotMon–Sat, 09:30–18:30 IST
VAQORACHEMICALS
Impurity reference standards

Zolmitriptan impurities & reference standards

Characterised Zolmitriptan impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.

26reference materials
2nitrosamine impurities
1isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Zolmitriptan
139264-17-8 · C16H21N3O2
View API
IP/BP/USP
Zolmitriptan chemical structure
Zolmitriptan
CAS
139264-17-8
Formula
C16H21N3O2
MW
287.36 g/mol
VQ-004074
Reference Standard
Zolmitriptan WS chemical structure
Zolmitriptan WS
CAS
139264-17-8
Formula
C16H21N3O2
MW
287.36 g/mol
In stock
Reference Standard
Zolmitriptan-d6 chemical structure
Zolmitriptan-d6
CAS
1217644-84-2
Formula
C16H21N3O2
MW
293.39 g/mol
VQ-043015

FAQs — Zolmitriptan impurities

Which Zolmitriptan impurities do you supply?

We list 26 Zolmitriptan-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.

What are Zolmitriptan impurity standards used for?

They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).

Can you synthesise a Zolmitriptan impurity that is not listed?

Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.

Request Zolmitriptan impurity standards

We reply within one business day with price, pack options, lead time and documentation.

By submitting you agree to our privacy policy. We never share your details.